NO774312L - Ne ny cellelinje, samt fremgangsmaate for viderefoering av den - Google Patents

Ne ny cellelinje, samt fremgangsmaate for viderefoering av den

Info

Publication number: NO774312L
Authority: NO; Norway
Prior art keywords: cells; culture; cell; medium; cell line
Prior art date: 1976-12-16

Application number

NO774312A

Other languages

English (en)

Norwegian (no)

Inventor

Dimitri Viza

Original Assignee

Int Inst Of Differentiation

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1976-12-16

Filing date

1977-12-14

Publication date

1978-06-19

1977-12-14 Application filed by Int Inst Of Differentiation filed Critical Int Inst Of Differentiation

1978-06-19 Publication of NO774312L publication Critical patent/NO774312L/no

Links

238000000034 method Methods 0.000 title claims description 15
210000004027 cell Anatomy 0.000 claims description 79
239000002609 medium Substances 0.000 claims description 16
235000015097 nutrients Nutrition 0.000 claims description 12
238000004113 cell culture Methods 0.000 claims description 9
108091003079 Bovine Serum Albumin Proteins 0.000 claims description 7
239000012894 fetal calf serum Substances 0.000 claims description 7
238000004114 suspension culture Methods 0.000 claims description 7
239000012980 RPMI-1640 medium Substances 0.000 claims description 5
239000001963 growth medium Substances 0.000 claims description 4
230000003068 static effect Effects 0.000 claims description 4
230000000644 propagated effect Effects 0.000 claims description 3
238000009987 spinning Methods 0.000 claims description 3
229920001817 Agar Polymers 0.000 claims description 2
210000000712 G cell Anatomy 0.000 claims description 2
239000006146 Roswell Park Memorial Institute medium Substances 0.000 claims description 2
239000008272 agar Substances 0.000 claims description 2
238000011081 inoculation Methods 0.000 claims 1
239000008188 pellet Substances 0.000 claims 1
230000001902 propagating effect Effects 0.000 claims 1
239000000427 antigen Substances 0.000 description 8
102000036639 antigens Human genes 0.000 description 8
108091007433 antigens Proteins 0.000 description 8
210000000265 leukocyte Anatomy 0.000 description 8
150000007523 nucleic acids Chemical class 0.000 description 8
102000039446 nucleic acids Human genes 0.000 description 8
108020004707 nucleic acids Proteins 0.000 description 8
241000282414 Homo sapiens Species 0.000 description 6
239000000385 dialysis solution Substances 0.000 description 5
238000004519 manufacturing process Methods 0.000 description 5
239000000463 material Substances 0.000 description 5
241000700605 Viruses Species 0.000 description 3
230000001900 immune effect Effects 0.000 description 3
230000006698 induction Effects 0.000 description 3
210000004698 lymphocyte Anatomy 0.000 description 3
239000006228 supernatant Substances 0.000 description 3
239000000725 suspension Substances 0.000 description 3
241001465754 Metazoa Species 0.000 description 2
230000000890 antigenic effect Effects 0.000 description 2
210000000349 chromosome Anatomy 0.000 description 2
238000010367 cloning Methods 0.000 description 2
238000011161 development Methods 0.000 description 2
230000004069 differentiation Effects 0.000 description 2
210000003743 erythrocyte Anatomy 0.000 description 2
210000002865 immune cell Anatomy 0.000 description 2
210000005259 peripheral blood Anatomy 0.000 description 2
239000011886 peripheral blood Substances 0.000 description 2
230000009257 reactivity Effects 0.000 description 2
238000011160 research Methods 0.000 description 2
238000012546 transfer Methods 0.000 description 2
FUFLCEKSBBHCMO-UHFFFAOYSA-N 11-dehydrocorticosterone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 FUFLCEKSBBHCMO-UHFFFAOYSA-N 0.000 description 1
102000007644 Colony-Stimulating Factors Human genes 0.000 description 1
108010071942 Colony-Stimulating Factors Proteins 0.000 description 1
MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 1
MFYSYFVPBJMHGN-UHFFFAOYSA-N Cortisone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)(O)C(=O)CO)C4C3CCC2=C1 MFYSYFVPBJMHGN-UHFFFAOYSA-N 0.000 description 1
241000282412 Homo Species 0.000 description 1
108060003951 Immunoglobulin Proteins 0.000 description 1
206010028980 Neoplasm Diseases 0.000 description 1
206010034719 Personality change Diseases 0.000 description 1
239000003470 adrenal cortex hormone Substances 0.000 description 1
238000004458 analytical method Methods 0.000 description 1
230000000721 bacterilogical effect Effects 0.000 description 1
210000004369 blood Anatomy 0.000 description 1
239000008280 blood Substances 0.000 description 1
201000011510 cancer Diseases 0.000 description 1
230000030833 cell death Effects 0.000 description 1
230000007969 cellular immunity Effects 0.000 description 1
229960004544 cortisone Drugs 0.000 description 1
238000012136 culture method Methods 0.000 description 1
230000001086 cytosolic effect Effects 0.000 description 1
238000000635 electron micrograph Methods 0.000 description 1
210000002472 endoplasmic reticulum Anatomy 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
239000012737 fresh medium Substances 0.000 description 1
239000011521 glass Substances 0.000 description 1
239000005556 hormone Substances 0.000 description 1
229940088597 hormone Drugs 0.000 description 1
210000005260 human cell Anatomy 0.000 description 1
238000010166 immunofluorescence Methods 0.000 description 1
102000018358 immunoglobulin Human genes 0.000 description 1
229940072221 immunoglobulins Drugs 0.000 description 1
238000000338 in vitro Methods 0.000 description 1
238000001727 in vivo Methods 0.000 description 1
230000000977 initiatory effect Effects 0.000 description 1
230000007774 longterm Effects 0.000 description 1
210000001165 lymph node Anatomy 0.000 description 1
210000005210 lymphoid organ Anatomy 0.000 description 1
210000002540 macrophage Anatomy 0.000 description 1
230000003211 malignant effect Effects 0.000 description 1
238000010899 nucleation Methods 0.000 description 1
230000003287 optical effect Effects 0.000 description 1
230000000242 pagocytic effect Effects 0.000 description 1
239000002245 particle Substances 0.000 description 1
108010088880 plasmagel Proteins 0.000 description 1
230000000717 retained effect Effects 0.000 description 1
238000004062 sedimentation Methods 0.000 description 1
210000000130 stem cell Anatomy 0.000 description 1
238000003756 stirring Methods 0.000 description 1
238000012360 testing method Methods 0.000 description 1
210000001519 tissue Anatomy 0.000 description 1
229960005486 vaccine Drugs 0.000 description 1
230000003612 virological effect Effects 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0635—B lymphocytes

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Life Sciences & Earth Sciences (AREA)
Zoology (AREA)
Chemical & Material Sciences (AREA)
Biotechnology (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Genetics & Genomics (AREA)
Immunology (AREA)
Wood Science & Technology (AREA)
Microbiology (AREA)
Hematology (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Cell Biology (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Data Exchanges In Wide-Area Networks (AREA)
Vehicle Body Suspensions (AREA)
Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)

NO774312A 1976-12-16 1977-12-14 Ne ny cellelinje, samt fremgangsmaate for viderefoering av den NO774312L (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB52675/76A GB1592954A (en)	1976-12-16	1976-12-16	Cell line

Publications (1)

Publication Number	Publication Date
NO774312L true NO774312L (no)	1978-06-19

Family

ID=10464838

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO774312A NO774312L (no)	1976-12-16	1977-12-14	Ne ny cellelinje, samt fremgangsmaate for viderefoering av den

Country Status (13)

Country	Link
US (1)	US4316962A (da)
JP (1)	JPS5386077A (da)
AT (1)	AT353408B (da)
BE (1)	BE861858A (da)
CA (1)	CA1117044A (da)
DK (1)	DK557577A (da)
ES (1)	ES465060A1 (da)
FI (1)	FI773785A7 (da)
FR (1)	FR2374418A1 (da)
GB (1)	GB1592954A (da)
LU (1)	LU78689A1 (da)
NL (1)	NL7713834A (da)
NO (1)	NO774312L (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8614733D0 (en) *	1986-06-17	1986-07-23	Lefesvre A	Aids treatment
AU7317400A (en) *	1999-09-21	2001-04-24	Chugai Research Institute For Molecular Medicine, Inc.	Transporter genes oatp-b, c, d and e

1976
- 1976-12-16 GB GB52675/76A patent/GB1592954A/en not_active Expired
1977
- 1977-12-14 DK DK557577A patent/DK557577A/da unknown
- 1977-12-14 FI FI773785A patent/FI773785A7/fi not_active Application Discontinuation
- 1977-12-14 ES ES465060A patent/ES465060A1/es not_active Expired
- 1977-12-14 US US05/860,439 patent/US4316962A/en not_active Expired - Lifetime
- 1977-12-14 NL NL7713834A patent/NL7713834A/xx not_active Application Discontinuation
- 1977-12-14 JP JP15040777A patent/JPS5386077A/ja active Pending
- 1977-12-14 FR FR7737743A patent/FR2374418A1/fr active Granted
- 1977-12-14 CA CA000293060A patent/CA1117044A/en not_active Expired
- 1977-12-14 NO NO774312A patent/NO774312L/no unknown
- 1977-12-14 LU LU78689A patent/LU78689A1/xx unknown
- 1977-12-14 BE BE183461A patent/BE861858A/xx unknown
- 1977-12-14 AT AT895077A patent/AT353408B/de not_active IP Right Cessation

Also Published As

Publication number	Publication date
ATA895077A (de)	1979-04-15
JPS5386077A (en)	1978-07-29
GB1592954A (en)	1981-07-15
NL7713834A (nl)	1978-06-20
US4316962A (en)	1982-02-23
FI773785A7 (fi)	1978-06-17
FR2374418A1 (fr)	1978-07-13
DK557577A (da)	1978-06-17
LU78689A1 (fr)	1979-06-13
ES465060A1 (es)	1978-09-01
BE861858A (fr)	1978-06-14
CA1117044A (en)	1982-01-26
FR2374418B3 (da)	1981-02-06
AT353408B (de)	1979-11-12

Publication	Publication Date	Title
Siegel	1960	Hereditary endosymbiosis in Paramecium bursaria
Pontén	1975	Neoplastic human glia cells in culture
EP0043718B1 (en)	1984-11-28	Improvements in or relating to cell lines
EP0014519B1 (en)	1983-04-06	Cell lines, process for preparing them and process for producing antibodies
NO774311L (no)	1978-06-19	Fremgangsmaate ved fremstilling av immunologiske materialer
Evans et al.	1966	Effect of Serum on Spontaneous Neoplastic Transformations In Vitro ¹
Barski et al.	1963	Malignant transformation in vitro of cells from C57BL mouse normal pulmonary tissue
Gabelman et al.	1975	Appearance of C‐type virus‐like particles after co‐cultivation of a human tumor‐cell line with rat (XC) cells
Minowada et al.	1967	Studies of Burkitt lymphoma cells. I. Establishment of a cell line (B35M) and its characteristics
Högman	1960	Blood group antigens on human cells in tissue culture: The effect of prolonged cultivation
DK0460414T3 (da)	1995-07-10	Dyrknings- og detektionsfremgangsmåde til sterilfiltrerbare, autonomt replikerende biologiske partikler
JPH0588116B2 (da)	1993-12-21
Massicot et al.	1971	Cell line derived from a murine sarcoma virus (Moloney pseudotype)-induced tumor: cultural, antigenic, and virological properties
WO2008023786A1 (en)	2008-02-28	Method for producing virus-specific ctl
NO774312L (no)	1978-06-19	Ne ny cellelinje, samt fremgangsmaate for viderefoering av den
WATANABE et al.	1965	Virus-specific proteins produced in HeLa cells infected with poliovirus: characterization of subunit-like protein
Olsen et al.	1976	Influence of culture conditions on growth of FL-74 cells and feline oncornavirus cell membrane associated antigen production
Takemoto et al.	1966	Hamster tumor cells doubly transformed by SV40 and polyoma viruses
Ishimoto et al.	1972	Presence of antibody against mouse fetal antigen in the sera from C57BL/6 mice immunized with Rauscher leukemia
EP0251106A2 (en)	1988-01-07	Improved fusion method
EP0103081B1 (en)	1991-12-04	Method of growing cells in vitro
US3432595A (en)	1969-03-11	Melanoma cell line of canine origin,its propagation and use,and vaccines derived therefrom
EP0077571A2 (en)	1983-04-27	Process for producing a lymphokine
Premkumar-Reddy et al.	1976	Continuous culturing of murine splenic B-lymphocytes: Synthesis and surface deposition of IgM and putative IgD molecules
Bertini et al.	1974	A tumour-associated membrane antigen transiently expressed by normal cells during mitosis